Legend Biotech Corporation

Direct answer

Legend Biotech Corporation is publicly traded on NASDAQ under the ticker LEGN.

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM)....

Can you invest in Legend Biotech Corporation?

Yes. Legend Biotech Corporation trades publicly on NASDAQ as LEGN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Legend Biotech Corporation

Detailed equity research is provided by MarketSnap.